Thomé, S.D. and Petz, L.D. (2002) Manual of Clinical Hematology. In: Mazza, J.J., Ed., Hemolytic Anemia: Hereditary and Acquired, Lippincott Williams and Wilkins, Pennsylvania, 90-117.
has been cited by the following article:
TITLE: Drug-Induced Hemolytic Anemia: A Fatal Complication Further Under-Recognized in Sickle Cell Disease
AUTHORS: Monica Khurana, Shekhar S. Raj
KEYWORDS: Sickle Cell, Hemolytic Anemia, Blood Bank, Pathology
JOURNAL NAME: Open Journal of Blood Diseases, Vol.7 No.3, September 25, 2017
ABSTRACT: Drug-induced immune hemolytic anemia (DIIHA) is commonly attributed to cephalosporins. Ceftriaxone is the most frequently administered cephalosporin in patients with sickle cell disease. We present a pediatric patient with severe DIIHA (hemoglobin